Core Viewpoint - Envestnet plans to sell its subsidiary Yodlee to private equity firm STG, allowing Envestnet to focus on its core wealth management offerings [1][4]. Group 1: Transaction Details - The sale of Yodlee is expected to close in the third quarter, pending customary closing conditions [2]. - STG specializes in investing in innovative software, data, and analytics firms, and Yodlee will be integrated into STG's global technology portfolio [2]. Group 2: Strategic Implications - STG's managing director, Marc Bala, stated that the partnership will enhance Yodlee's investment in product innovation, customer success, and long-term growth [3]. - Yodlee aims to focus on technological innovation and improved solutions for the financial sector with STG's support [3]. Group 3: Envestnet's Focus - Envestnet's CEO, Chris Todd, indicated that the transaction will enable the company to concentrate on its core offerings, including its wealth management platform [4]. - Envestnet retains access to Yodlee's data aggregation technology, which is essential for financial advisors [5]. Group 4: Company Background - Envestnet became a private company in November after being acquired by Bain Capital affiliates in a deal valued at approximately $4.5 billion [5]. - The company reported $6.5 trillion in platform assets, over 20 million accounts, and services more than 111,000 financial advisors [6]. - Envestnet is enhancing its wealth management solutions by investing in tax intelligence, trading flexibility, client engagement, and advisor productivity [6]. Group 5: Historical Context - Envestnet acquired Yodlee in 2015 for a cash and stock transaction valued at about $660 million [7].

Core Insights - Federal Life Insurance Company has acquired Texas Service Life Insurance Company, enhancing its position in the preneed insurance market and demonstrating a commitment to growth and innovative solutions for families [1][3] - The acquisition is seen as a strategic move to address an underserved market, with Federal Life aiming to redefine how families prepare for the future through exceptional service and innovative preplanning opportunities [3][4] - Federal Life holds an A- (Excellent) rating from AM Best and is backed by Bain Capital, indicating a strong financial foundation for future growth in the preneed insurance sector [2] Company Overview - Federal Life Insurance Company focuses on innovative insurance solutions that protect individuals and families throughout their lives, emphasizing financial strength and stability [5] - Texas Service Life Insurance Company has been operational since 1985, known for its reliability and strong financial foundation in the insurance industry [6] Leadership and Strategy - Knut Olson, CEO of Federal Life, emphasizes the importance of preneed insurance as a vital product for families and the company's readiness to drive industry change [3] - George Wise has been appointed as President of Texas Service Life, tasked with leading a national expansion strategy that prioritizes accessibility and financial security for families [3][4]

Core Viewpoint - Rosen Law Firm is reminding investors who sold or held shares of Cerevel Therapeutics Holdings, Inc. during a specified period about their potential entitlement to compensation through a class action lawsuit [1][2]. Group 1: Class Action Details - The class period for the lawsuit is from October 11, 2023, to August 1, 2024, and includes those who held shares as of January 8, 2024, and those who sold shares around Bain Capital's purchase on October 16, 2023 [1]. - A class action lawsuit has already been filed, and interested parties can join by contacting Rosen Law Firm [3][6]. - The deadline to serve as lead plaintiff is June 3, 2025, which requires a motion to the Court [3]. Group 2: Legal Representation - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [4]. - The firm has a history of significant settlements, including over $438 million recovered for investors in 2019 alone [4]. Group 3: Case Allegations - The lawsuit alleges that during the class period, Cerevel's controlling shareholders made false and misleading statements related to a secondary stock offering on October 16, 2023 [5]. - The secondary offering was purportedly designed to allow Bain Capital to increase its stake in Cerevel at a discounted price before AbbVie Inc.'s acquisition announcement, which was made just 51 days later at $45 per share, nearly double the offering price [5].

Core Viewpoint - Rosen Law Firm is reminding investors who sold or held shares of Cerevel Therapeutics Holdings, Inc. during a specified period about their potential entitlement to compensation through a class action lawsuit [1][2]. Group 1: Class Action Details - The class period for the lawsuit is from October 11, 2023, to August 1, 2024, and includes those who held shares as of January 8, 2024, and those who sold shares around Bain Capital's purchase on October 16, 2023 [1]. - Investors may join the class action without incurring out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move to serve as lead plaintiff by June 3, 2025 [3]. Group 2: Case Allegations - The lawsuit alleges that during the class period, Cerevel's controlling shareholders made false and misleading statements related to a secondary stock offering on October 16, 2023, and a proxy statement on January 18, 2024 [5]. - The secondary stock offering was purportedly designed to allow Bain Capital to increase its stake in Cerevel at a discounted price before AbbVie Inc.'s acquisition announcement [5]. - Following the offering, AbbVie announced its acquisition of Cerevel for $45 per share, nearly double the offering price, resulting in Bain Capital receiving over $120 million in windfall profits [5]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [4]. - The firm has achieved significant settlements in the past, including over $438 million for investors in 2019 and has been ranked highly in securities class action settlements since 2013 [4].

Core Viewpoint - Rosen Law Firm is reminding investors who sold or held shares of Cerevel Therapeutics Holdings, Inc. during a specified period about their potential entitlement to compensation through a class action lawsuit [1][2]. Group 1: Class Action Details - The class period for the lawsuit is from October 11, 2023, to August 1, 2024, and includes those who held shares as of January 8, 2024, and those who sold shares around Bain Capital's purchase on October 16, 2023 [1]. - Investors may join the class action without any out-of-pocket fees through a contingency fee arrangement [2]. - A lead plaintiff must be appointed by June 3, 2025, to represent other class members in the litigation [3]. Group 2: Legal Representation - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions [4]. - The firm has achieved significant settlements in the past, including over $438 million for investors in 2019 and has been consistently ranked among the top firms in securities class action settlements [4]. Group 3: Case Allegations - The lawsuit alleges that during the class period, Cerevel's controlling shareholders made false statements related to a secondary stock offering on October 16, 2023, which allowed Bain Capital to acquire shares at a discounted price before AbbVie Inc.'s acquisition announcement [5]. - Following the acquisition announcement, Cerevel's stock was valued at $45 per share, nearly double the offering price, resulting in Bain Capital receiving over $120 million in windfall profits [5].

Core Viewpoint - Rosen Law Firm is reminding investors who sold or held shares of Cerevel Therapeutics Holdings, Inc. during a specified period about their potential entitlement to compensation through a class action lawsuit [1][2]. Group 1: Class Action Details - The class period for the lawsuit is from October 11, 2023, to August 1, 2024, and includes those who held shares as of January 8, 2024, and those who sold shares around Bain Capital's purchase on October 16, 2023 [1]. - Investors can join the class action without any out-of-pocket fees through a contingency fee arrangement [2]. - A lead plaintiff must be appointed by June 3, 2025, to represent other class members in the litigation [3]. Group 2: Case Allegations - The lawsuit alleges that during the class period, Cerevel's controlling shareholders, Bain Capital and Pfizer, made false statements related to a secondary stock offering on October 16, 2023, and a proxy statement on January 18, 2024 [5]. - The secondary stock offering allowed Bain Capital to acquire shares at a discounted price before AbbVie Inc.'s acquisition announcement, which was made just 51 days later at $45 per share, nearly double the offering price [5]. - Bain Capital's discounted purchases from the offering resulted in a windfall of over $120 million when the true details were revealed [5]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest settlement against a Chinese company at the time and being ranked No. 1 for securities class action settlements in 2017 [4]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4]. - Many attorneys at the firm have received recognition from Lawdragon and Super Lawyers, highlighting their expertise in this area [4].

这是美国流行文化有史以来最糟糕的时代吗？ 最近，《大西洋月刊》（The Atlantic）旗下撰稿人Spencer Kornhaber写了一篇文章来论述这个命题，引发了不少音乐行业从业者关注。 这位记者采访了美国知名音乐历史学者Ted Gioia，后者直言不讳地指出，当代文化创作已陷入创造力枯竭的困境，艺术与娱乐的整体质感正在肉眼可见地 滑坡，其影响甚至辐射至一个国家的社会情绪与政治稳定。 尤其是音乐行业，愈来愈多的观察者质疑，音乐越来越不像一项艺术创作，更像一项由资本驱动的资产管理。甚至认为，大批私募公司的涌入，让经典曲 库不断侵蚀新作品的曝光与流通空间，令音乐生态逐渐趋于封闭与保守。 那么，在收听人群愈加全球化、创作环境空前开放的背景下，这种"经典老歌压倒新音乐"的论调真的成立吗？私募公司是否真正搅乱了音乐行业的市场？ 音乐行业的"衰落论" 近几年，音乐市场的"衰落叙事"已经成为美国顶级文学刊物中的敏感话题。 2023年，《纽约时报》一篇报道宣称，我们正处于自印刷术发明以来，文化上最缺乏创新、最缺乏变革、最缺乏开拓精神的世纪。 最近，数据分析公司YouGov的民意调查显示，美国人认为2020年代是一个世纪 ...

Core Insights - Nutanix has appointed Eric K. Brandt to its board of directors, effective May 15, 2025, bringing extensive leadership and finance experience [2][3] - David Humphrey has resigned from Nutanix's board, effective the same date, after serving since Bain Capital's $750 million investment in September 2020 [4][5] Company Leadership Changes - Eric K. Brandt has over 30 years of global experience in finance, operations, and corporate governance, having served as CFO of Broadcom and held senior roles at Avanir Pharmaceuticals and Allergan [3] - Virginia Gambale, Chair of the Board, expressed confidence that Brandt's expertise will benefit Nutanix as it focuses on sustainable growth and customer service [3] - David Humphrey's resignation was acknowledged positively, highlighting his contributions during a transformative period for Nutanix [5] Company Performance and Strategy - Since Bain Capital's investment, Nutanix has significantly grown and evolved into a leader in hybrid multicloud computing, enhancing its profits and cash flows [5] - The company aims to provide a single platform for running applications and managing data, simplifying operations for organizations [6]

Financial Data and Key Metrics Changes - Adjusted operating income increased by 14% year over year, demonstrating continued execution of strategic initiatives [7][22] - First quarter adjusted operating income available to common stockholders was $280 million, or $1.60 per diluted share [23] - Net loss available to common shareholders was $756 million, or $4.41 per diluted share, primarily due to negative movements in market risk benefits [23][24] Business Line Data and Key Metrics Changes - Group Protection business saw a 26% year-over-year increase in earnings and 120 basis points of margin expansion [10][24] - Annuities reported operating income of $290 million, consistent with the prior year quarter, with total sales of $3.8 billion increasing 33% year over year [11][29] - Life insurance segment reported an operating loss of $16 million, an improvement from a loss of $35 million in the prior year quarter [33] Market Data and Key Metrics Changes - Total deposits in Retirement Plan Services increased by 8%, driven by growth in recurring deposits [20][32] - Group sales grew 9% year over year, with all market segments contributing to this result [16] - Annuity account balances net of reinsurance ended the quarter 5% above the prior year period [29] Company Strategy and Development Direction - The company is focusing on diversifying its business mix and enhancing operational efficiency to manage through market turbulence [6][10] - A long-term partnership with Bain Capital is expected to enhance growth in spread-based products and improve capital deployment [9][39] - The strategic emphasis on growing group business has increased its contribution to operating earnings from less than 10% pre-COVID to over 25% today [45] Management's Comments on Operating Environment and Future Outlook - Management acknowledged high market volatility and an uncertain external backdrop but expressed confidence in the company's resilience and strategic positioning [5][6] - The company is well-prepared to navigate potential economic downturns, maintaining a capital buffer above its 400% target [7][44] - Management remains focused on disciplined execution and advancing strategic priorities to deliver long-term shareholder value [21][46] Other Important Information - The alternative investments portfolio delivered a 7.6% annualized return in the quarter, though it was below the target [23][38] - The company ended the quarter with an estimated RBC ratio well above 420%, consistent with its strategy [37] Q&A Session Summary Question: Insights on Bain partnership and expected free cash flow improvement - Management indicated that the improvement in free cash flow per share is driven by capital deployment into growth areas, not share repurchases [48] Question: Favorability of mortality in the life business - Management noted that mortality was favorable relative to expectations, with first quarter typically being seasonally higher [50] Question: Rationale for issuing new equity to Bain instead of open market purchase - Management emphasized the importance of alignment and the ability to utilize capital for growth, which would not be feasible through open market purchases [56][58] Question: Impact of large plan termination on Retirement Plan Services - Management confirmed that a large case termination affected net outflows but noted that excluding this, flows were positive [78] Question: Update on expense initiatives and their impact - Management confirmed that expense reductions are emerging from operational efficiencies and that reinvestments are being made in growth areas [83]

Financial Data and Key Metrics Changes - Adjusted operating income increased by 14% year over year, demonstrating continued execution of strategic initiatives [6][10] - First quarter adjusted operating income available to common stockholders was $280 million, or $1.60 per diluted share [24] - Net loss available to common shareholders was $756 million, or $4.41 per diluted share, primarily due to negative movements in market risk benefits [25][26] Business Line Data and Key Metrics Changes - Group Protection business saw a 26% year-over-year increase in earnings and 120 basis points of margin expansion [10][16] - Annuities reported first quarter operating income of $290 million, consistent with the prior year quarter [30] - Life insurance segment reported a first quarter operating loss of $16 million, an improvement from a loss of $35 million in the prior year [34] Market Data and Key Metrics Changes - Total deposits in Retirement Plan Services grew by 8%, driven by a 13% increase in recurring deposits [33] - Group sales grew by 9% year over year, with all market segments contributing to this result [17] - Annuities total sales reached $3.8 billion, a 33% increase from the prior year quarter [11] Company Strategy and Development Direction - The company is focusing on diversifying its business mix and enhancing operational efficiency to manage market volatility [5][10] - A long-term partnership with Bain Capital is expected to enhance growth in spread-based products and improve capital deployment [9][40] - The strategic emphasis on growing group business has increased its contribution to operating earnings from less than 10% pre-COVID to over 25% today [46] Management's Comments on Operating Environment and Future Outlook - Management acknowledged high market volatility and an uncertain external backdrop but expressed confidence in the company's resilience and strategic positioning [4][10] - The company is well-prepared to navigate potential economic downturns due to proactive capital management and diversified earnings sources [38][46] - Management remains focused on disciplined execution and believes current actions will lead to sustainable long-term value [47] Other Important Information - The company maintains an estimated RBC ratio well above 420%, providing a buffer against adverse economic conditions [7][38] - The alternative investments portfolio delivered a 7.6% annualized return in the quarter, though it was below the target [25][39] Q&A Session Summary Question: Insights on the Bain partnership and expected free cash flow improvements - Management indicated that the capital from Bain will be deployed to grow spread-based earnings and optimize the legacy LifeBlock, with no immediate plans for share repurchases [49] Question: Favorability of mortality in the life business - Management noted that mortality was better than expected, with first quarter typically being seasonally higher [50][51] Question: Rationale for issuing new equity to Bain instead of open market purchases - Management emphasized the importance of alignment with Bain and the ability to utilize capital for growth, which would not be feasible through open market purchases [56][59] Question: Annuity business ROA trends - Management acknowledged that the decline in ROA is due to a shift in business mix, with a focus on growing RILA and fixed annuities [64] Question: RBC ratio sensitivity to macro volatility - Management clarified that the RBC ratio remains stable and is not materially affected by recent market conditions [69] Question: Impact of large plan termination on Retirement Plan Services - Management confirmed that a large case termination affected net outflows but overall flows were positive excluding this event [80]